pembrolizumabEnfortumab vedotinaUCEV/PSignatera™urothelial cancer
…ve biomarker in patients with aUC commencing EV with or without pembrolizumab.Methods We conducted a multicenter, retrospective real-world an…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 1,501–1,560 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Rese-cel2SCIg2STK-0122TYRX2Vibostolimab2rTOPO2rhIL-152A. muciniphila2AM2ATTR-012B/F/TAF2BILAG-20042BZN2Bexotegrast2BoNT2Ceftazidime-avibactam-aztreonam2Cloxacillin2Colesevelam2FCSEMS2Fumarate2HP2Inavolisib2Iscalimab2Loberamisal2MTZ2Magic Glue2NAM2ORMDL32Ortho-k2PBMT-sMF2PTZ2Pembro2Peripherin2Surpass Elite2SynKIR-1102Telmisartan2XTRA·42aminophylline2chloroprocaine2lorlatinib26-MP268Ga2Anlotinib2BI 10155502Brimonidine2CALPRO22CAR-M2Cefoperazone/sulbactam2Cy/Flu2FRIDs2Fluticasone2GRemubamab2HFA-152a2Masimo2Obe2Obe-252PITSTOP2Patiromer2PuraStat2Resistin2
Articles mentioning drugs
10,506 articles · page 447 of 876opioidsnon-cardioselective beta-blockerscancerRADIOHEAD study
…suggest that specific medication classes, particularly baseline opioids and beta-blockers, may strongly contribute to this association.…
nivolumabipilimumabcobolimabSingapore General HospitalTNBC
… humanized mice models treated with immunotherapy combinations (nivolumab, ipilimumab, cobolimab)-coupled LSD1 inhibitor significantly re…
pembrolizumabUniversity of Southern CaliforniaUniversity of Florida College of MedicineWashington UniversityUniversity of Southern California Keck School of MedicineWashington University in St. Louis School of MedicineUniversity of FloridaIDH-wildtype glioblastomarHGALaser interstitial thermal therapy
…LITT+PEM) or non-LITT surgery (biopsy or resection) followed by pembrolizumab (NLS+PEM). After 21 patients, randomization was halted when eme…
C3aR-AThepatocellular carcinomaHCCliver cancercancer
…gnaling in sustaining tumor growth in this model. Additionally, C3aR-AT treatment led to a ~23.9-fold increase in neutrophil infiltrati…
Tisotumab vedotinHNSCCPfizerSeagen Inc.GenmabNucleus Globalantibody-drug conjugate (ADC) therapies
…mmunother Cancer. 2020;8:A371.Sun L, Fayette J, Salas S, et al. Tisotumab vedotin in head and neck squamous cell carcinoma: updated analysis from…
huCART19-IL18chronic lymphocytic leukemiaB-cell malignanciesnon-Hodgkin lymphomaNEJMNEJMoa2408771
…ty. In Cohorts A-C of the ongoing Phase I study ( NCT04684563), huCART19-IL18 exhibited a manageable safety profile and encouraging antitumor…
survivinWT1PRAMEr/r solid tumorsosteosarcomaWilms tumorChildren’s National Hospital’s Institutional Review BoardneuroblastomaDepartment of Defense Peer Reviewed Cancer Research Program Career Development Award
…igen-specific T cell (TAA-T) products targeting WT1, PRAME, and survivin have been safely administered to patients with r/r disease with…
PD-1 inhibitorshead and neck squamous cell carcinoma (HNSCC)HNSCCcutaneous squamous cell carcinomaCSCCadvanced cutaneous squamous cell carcinoma (CSCC)
…carcinoma (HNSCC)—which shares histology but responds poorly to PD-1 inhibitors—may offer new insights into CSCC pathogenesis and immune respon…
SECN-15breast cancergastric cancer
…Background SECN-15 is a high-affinity antisense oligonucleotide (ASO) designed to …
tamoxifenCCL19head and neck squamous cell carcinoma
…). (D) Schematic: ROSA26 x Ai9 mice treated with tdRT→αPD-1 and tamoxifen, followed by SLN mapping and CITE-seq of sorted tdTomato+ cells…
ME1
…s of cytotoxic function. Notably, even in resting CD8+ T cells, ME1 OE induced higher expression of Fasl, Gzmk, and Gzmb. According…